Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Bank of America reissued a “neutral” rating and set a $173.00 price objective on shares of Apple in a research report on Tuesday, October 24th.
Bank of America reissued a “neutral” rating and set a $173.00 target price on shares of Apple in a research note on Tuesday, October 24th.
Benchmark reissued a “buy” rating and set a $50.00 price target on shares of Halliburton in a report on Monday, April 3rd.
Benchmark reissued an overweight rating and issued a $6.00 price target on shares of Pagaya Technologies in a research report on Friday, September 8th.
Source: https://www.etfdailynews.com/2023/10/20/pagaya-technologies-nasdaqpgy-pt-lowered-to-2-25/
Berenberg Bank reissued a “buy” rating and set a GBX 820 ($10.26) price target on shares of HSBC in a research report on Monday, October 30th.
Source: https://www.etfdailynews.com/2023/11/26/hsbc-lonhsba-stock-rating-lowered-by-royal-bank-of-canada/
BMO Capital Markets reissued a market perform rating and issued a $31.00 price objective on shares of ImmunoGen in a research note on Friday.
B. Riley reissued a “neutral” rating and issued a $111.00 price target on shares of Dycom Industries in a report on Thursday, August 24th.
Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price target on shares of AvePoint in a research report on Monday, September 18th.
Source: https://www.etfdailynews.com/2023/10/04/avepoint-nasdaqavpt-trading-3-3-higher/
Cantor Fitzgerald reissued an “overweight” rating and issued a $215.00 price objective on shares of Johnson & Johnson in a report on Wednesday, February 1st.
Cantor Fitzgerald reissued an “overweight” rating and issued a $315.00 price objective on shares of HCA Healthcare in a research report on Thursday, September 14th.
Cantor Fitzgerald reissued an “overweight” rating and issued a $380.00 target price on shares of Vertex Pharmaceuticals in a report on Thursday.
Cantor Fitzgerald reissued an “overweight” rating and issued a $75.00 price objective on shares of Pfizer in a research report on Monday, November 20th.
Cantor Fitzgerald reissued an “overweight” rating and set a $135.00 price objective on shares of Merck & Co., Inc. in a report on Tuesday, September 5th.
Cantor Fitzgerald reissued an “overweight” rating and set a $215.00 target price on shares of Johnson & Johnson in a research report on Monday, October 2nd.
Chardan Capital reissued a “buy” rating and set a $60.00 price target on shares of Arrowhead Pharmaceuticals in a report on Friday, February 10th.
Citigroup reissued a “buy” rating and issued a $385.00 price objective on shares of Meta Platforms in a research report on Friday, September 22nd.
COM reissued a “maintains” rating on shares of Hasbro in a report on Friday, April 28th.
COM reissued a “maintains” rating on shares of Motorola Solutions in a research note on Friday, May 5th.
COM reissued an “initiates” rating on shares of Moody’s in a research report on Tuesday, May 9th.
Credit Suisse Group reissued a “neutral” rating and issued a $70.00 price objective on shares of Exact Sciences in a research note on Wednesday, February 22nd.